Stay updated with breaking news from Sciences Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Clinical Laboratory Services Market, 8th Edition" report has been added to ResearchAndMarkets.com's offering. Clinical Laboratory Services...
Traynor Capital Management Inc. raised its holdings in Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 61.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 25,528 shares of the medical research company’s stock after purchasing an additional 9,706 shares […]
1-800-FLOWERS.COM reissued their reiterates rating on shares of Exact Sciences (NASDAQ:EXAS – Get Rating) in a research note released on Thursday, Benzinga reports. Other research analysts have also recently issued reports about the stock. Cowen lifted their price target on shares of Exact Sciences from $56.00 to $76.00 and gave the company an outperform rating […]
Tuesday, Exact Sciences Corp (NASDAQ: EXAS) announced topline results from the pivotal BLUE-C study, showing that next-generation
Exact Sciences (NASDAQ:EXAS – Get Rating) had its price target raised by investment analysts at Citigroup from $100.00 to $130.00 in a research report issued on Thursday, The Fly reports. Citigroup’s price target would indicate a potential upside of 44.80% from the company’s previous close. Several other research analysts have also recently issued reports on […]